Sep 17, 2014 7:00am EDT Can Fite's Drug CF101 is Presented in Scientific Journal as One of Four Small Molecule Drugs for the Treatment of Psoriasis
Sep 05, 2014 7:00am EDT Can-Fite Issued Japanese Patent for CF102 in the Treatment of Liver Regeneration and Function Following Surgery
Sep 03, 2014 7:00am EDT Can-Fite to Present at Rodman & Renshaw Global Investment Conference in New York City on September 9, 2014
Aug 06, 2014 7:00am EDT New Data Shows High Efficacy for Can-Fite's CF101 in Rheumatoid Arthritis and Psoriasis Patients
Jul 21, 2014 7:00am EDT Can-Fite CEO to Deliver Scientific Presentation and Serve on Expert Panel at Purines 2014 in Bonn, Germany on July 23-27, 2014
Jul 10, 2014 7:00am EDT Can-Fite's CF102 Approved for Compassionate Use in Israel for Liver Cancer Patient
Jun 19, 2014 7:00am EDT Can-Fite to Exhibit at Bio International Convention in San Diego on June 23 - 26, 2014
Jun 17, 2014 7:00am EDT Can-Fite Completes Patient Enrollment in its Phase II/III Psoriasis Trial; Final Results are expected in Q1 2015
